StonvexLoading…
StonvexStonvexStonvexCore line items from CAVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-05-19 | Annual 2025 2025-12-28 | Q4 2025 2025-10-05 | Q3 2025 2025-07-13 | Q2 2025 2025-04-20 |
|---|---|---|---|---|---|
Revenue | $418.77M | $1.18B | $904.68M | $612.44M | $331.83M |
Operating Income | Not available | $55.28M | $52.48M | $35.35M | $15.71M |
Net Income | Not available | $63.74M | $58.82M | $44.08M | $25.71M |
EPS (Diluted) | $0.18 | $0.54 | $0.50 | $0.37 | $0.22 |
Total Assets | Not available | $1.36B | $1.32B | $1.29B | $1.23B |
Total Liabilities | Not available | $580.37M | $552.97M | $540.92M | $502.19M |
Cash & Equivalents | Not available | $282.92M | $284.57M | $290.17M | $289.35M |
Free Cash Flow OCF − CapEx | Not available | $26.14M | $23.27M | $21.90M | $2.70M |
Shares Outstanding | Not available | 116.13M | 115.98M | 115.95M | 115.66M |